Pediatr. praxi 2019; 20(3): 142-147 | DOI: 10.36290/ped.2019.029

The Use of Postbiotics in Pediatrics

MUDr. Petr Jabandžiev, Ph.D.1,2,3, MUDr. Jan Papež1,2, MUDr. Tereza Pinkasová1,2, MUDr. Jakub Pecl1,2, MUDr. Markéta Veverková1, MUDr. Lumír Kunovský, Ph.D.2,4,5
1 Pediatrická klinika, Fakultní nemocnice Brno
2 Lékařská fakulta Masarykovy univerzity v Brně
3 Středoevropský technologický institut – CEITEC, Brno
4 Chirurgická klinika, Fakultní nemocnice Brno
5 Interní gastroenterologická klinika, Fakultní nemocnice Brno

The optimal development of the gastrointestinal tract and the immune system is associated, among other things, with the proper development and composition of the intestinal microbiota. In addition to prebiotics, probiotics and synbiotics, so-called postbiotics may contribute to the modulation of microbial composition and thus to the development of both the gastrointestinal tract and the immune system. Postbiotics are metabolic compounds produced by the probiotic microbes and they affect various biological functions of the host at both local and systemic levels. Lately, in clinical practice, we can find fermented infant formulas containing postbiotics. This report gives an overview of the possible benefits of fermented formula with postbiotics and summarizes the current clinical evidence in this field.

Keywords: microbiota, children, postbiotics, infant formula

Published: June 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jabandžiev P, Papež J, Pinkasová T, Pecl J, Veverková M, Kunovský L. The Use of Postbiotics in Pediatrics. Pediatr. praxi. 2019;20(3):142-147. doi: 10.36290/ped.2019.029.
Download citation

References

  1. Ojeda P, Bobe A, Dolan K et al. Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology. J Nutr Biochem. 2015; 28: 191-200. Go to original source... Go to PubMed...
  2. West CE, Renz H, Jenmalm MC et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol. 2015; 135: 3-13. Go to original source... Go to PubMed...
  3. Mitsuoka T. Intestinal flora and aging. Nutr Rev. 1992; 50: 438-446. Go to original source... Go to PubMed...
  4. Furness JB, Kunze WA, Clerc N. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physio. 1999; 277: G922-928. Go to original source... Go to PubMed...
  5. Helander HF, Fändriks L. Surface area of the digestive tract - revisited. Scand J Gastroenterol. 2014; 49: 681-689. Go to original source... Go to PubMed...
  6. Wopereis H, Oozeer R, Knipping K et al. The first thousand days - intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immuno 2014; 25: 428-438. Go to original source... Go to PubMed...
  7. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab. 2010; 21: 199-205. Go to original source... Go to PubMed...
  8. Bischoff S. Gut health: a new objective in medicine? BMC Med. 2011; 9: 24. Go to original source... Go to PubMed...
  9. Houghteling PD, Walker WA. Why is initial bacterial colonization of the intestine important to infants' and children's health?. J Pediatr Gastroenterol Nutr. 2015; 60: 294-307. Go to original source... Go to PubMed...
  10. Belkaid Y, Harrison OJ. Homeostatic Immunity and the Microbiota. Immunity, 2017; 46: 562-576. Go to original source... Go to PubMed...
  11. Collado MC, Rautava S, Aakko J et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep. 2016; 6: 23129. Go to original source... Go to PubMed...
  12. Bergmann H, Rodriguez JM, Salminen S et al. Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report. Br J Nutr. 2014; 112: 1119-1128. Go to original source... Go to PubMed...
  13. Arrieta MC, Stiemsma LT, Amenyogbe N et al. The intestinal microbiome in early life: Health and disease. Front Immunol. 2014; 5: 42. Go to original source... Go to PubMed...
  14. Vandenplas Y, Savino F. Probiotics and Prebiotics in Pediatrics: What Is New? Nutrients. 2019; 11(2): 431. Go to original source... Go to PubMed...
  15. Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017; 9(9): 1021. Go to original source... Go to PubMed...
  16. Mugambi MN, Musekiwa A, Lombard M et al. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr J. 2012; 11: 81. Go to original source... Go to PubMed...
  17. Sýkora J. Prebiotika a kojenecká výživa. Pediatr Praxi. 2011; 12(3): 180-185.
  18. Klemashevich C. Rational idientifcation of diet-derived postbiotics for improving intestinal microbiota function. Curr Opin Biotechnol. 2014; 26: 85-90. Go to original source... Go to PubMed...
  19. Tsai YL, Lin TL, Chang CJ, et al. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci. 2019; 26(1): 3. Go to original source... Go to PubMed...
  20. Aguilar-Toalá JE, Garcia-Varela R, Garcia HS et al. Postbiotics: An evolving term within the functional foods field. Trends Food Sci Technol. 2018; 75: 105-114. Go to original source...
  21. Tsilingiri K, Rescigno M. Postbiotics: what else?. Benef Microbes, 2013; 4: 101-107. Go to original source... Go to PubMed...
  22. Aguilar-Toala JE, Santiago-Lopez L, Peres CM et al. Assessment of multifunctional activity of bioactive peptides derived from fermented milk by specific Lactobacillus plantarum strains. J Dairy Sci. 2017; 100(1): 65-75. Go to original source... Go to PubMed...
  23. Patel RM, Denning PW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol. 2013; 40(1): 11-25. Go to original source... Go to PubMed...
  24. Sah BN, Vasiljevic T, McKechnie S et al. Effect of probiotics on antioxidant and antimutagenic activities of crude peptide extract from yogurt. Food Chem. 2014; 156: 264-270. Go to original source... Go to PubMed...
  25. Fardet A, Rock E. In vitro and in vivo antioxidant potential of milks, yoghurts, fermented milks and cheeses: a narrative review of evidence. Nutr Res Rev. 2018; 31(1): 52-70. Go to original source... Go to PubMed...
  26. Marco ML, Heeney D, Binda S et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol. 2017; 44(4): 94-102. Go to original source... Go to PubMed...
  27. Granier A, Goulet O, Hoarau C. Fermentation products: immunological effects on human and animal models. Pediatr Res. 2013; 74(2): 238-244. Go to original source... Go to PubMed...
  28. van de Heijning BJ, Berton A, Bouritius H et al. GI symptoms in infants are a potential target for fermented infant milk formulae: a review. Nutrients. 2014; 6(9): 3942-3967. Go to original source... Go to PubMed...
  29. Chilton SN, Burton JP, Reid G. Inclusion of fermented foods in food guides around the world. Nutrients 2015; 7(1): 390-404 Go to original source... Go to PubMed...
  30. Gertosio C, Meazza C, Pagani S et al. Breastfeeding and its gamut of benefits. Minerva Pediatr. 2016; 68(3): 201-212. Go to PubMed...
  31. Agostoni C, Goulet O, Kolacek S et al. Fermented infant formulae without live bacteria. J. Pediatr. Gastroenterol. Nutr. 2007; 44: 392-397. Go to original source... Go to PubMed...
  32. Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 147-152. Go to original source... Go to PubMed...
  33. Szajewska H, Skórka A, Pieścik-Lech M. Fermented infant formulas without live bacteria: a systematic review. Eur J Pediatr. 2015 174: 1413. Go to original source... Go to PubMed...
  34. Roy P, Aubert-Jacquin C, Avart C et al. Benefits of a thickened infant formula with lactase activity in the management of benign digestive disorders in newborns. Arch. Pediatr. 2004; 11: 1546-1554. Go to original source... Go to PubMed...
  35. Huet F, Abrahamse-Berkeveld M, Tims S, et al. Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated. J Pediatr Gastroenterol Nutr. 2016; 63(4): e43-53. Go to original source... Go to PubMed...
  36. Vandenplas Y, Ludwig T, Bouritius H, et al. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic. Acta Paediatr. 2017; 106(7): 1150-1158. Go to original source... Go to PubMed...
  37. Morisset M. Aubert-Jacquin C, Soulaines P. et al. A non-hydrolysed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Eur. J. Clin. Nutr. 2011; 65: 175-183. Go to original source... Go to PubMed...
  38. Indrio F, Ladiza G, Mautone A et al. Effect of a fermented formula on thymus size and stool pH in healthy term infants. Pediatr. Res. 2007; 6: 98-100. Go to original source...
  39. Mullié C, Yazourh A, Thibault H et al. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: A randomized, double-blind, placebo-controlled trial. Pediatr. Res. 2004; 56: 791-795. Go to original source... Go to PubMed...
  40. Łukasik J, Salminen S, Szajewska H. Rapid review shows that probiotics and fermented infant formulas do not cause d-lactic acidosis in healthy children. Acta Paediatr. 2018 Aug; 107(8): 1322-1326. Go to original source... Go to PubMed...
  41. Huet F, Abrahamse-Berkeveld M, Tims S et al. Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated. J Pediatr Gastroenterol Nutr. 2016; 63(4): e43-53. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.